152 related articles for article (PubMed ID: 18639524)
21. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression.
Somasiri A; Nielsen JS; Makretsov N; McCoy ML; Prentice L; Gilks CB; Chia SK; Gelmon KA; Kershaw DB; Huntsman DG; McNagny KM; Roskelley CD
Cancer Res; 2004 Aug; 64(15):5068-73. PubMed ID: 15289306
[TBL] [Abstract][Full Text] [Related]
23. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
24. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
25. Strong c-Jun immunoreactivity is associated with apoptotic cell death in human tumors of the central nervous system.
Ferrer I; Seguí J; Olivé M
Neurosci Lett; 1996 Aug; 214(1):49-52. PubMed ID: 8873129
[TBL] [Abstract][Full Text] [Related]
26. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
28. RAF expression in human astrocytic tumors.
Hagemann C; Gloger J; Anacker J; Said HM; Gerngras S; Kühnel S; Meyer C; Rapp UR; Kämmerer U; Vordermark D; Flentje M; Roosen K; Vince GH
Int J Mol Med; 2009 Jan; 23(1):17-31. PubMed ID: 19082503
[TBL] [Abstract][Full Text] [Related]
29. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence.
Rickert CH; Paulus W
Acta Neuropathol; 2005 Jan; 109(1):69-92. PubMed ID: 15647946
[TBL] [Abstract][Full Text] [Related]
30. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
Schopperle WM; DeWolf WC
Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical markers for prognosis of anaplastic astrocytomas.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):203-15. PubMed ID: 12187956
[TBL] [Abstract][Full Text] [Related]
32. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
Facoetti A; Ranza E; Nano R
Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
[TBL] [Abstract][Full Text] [Related]
33. The role of podocalyxin in health and disease.
Nielsen JS; McNagny KM
J Am Soc Nephrol; 2009 Aug; 20(8):1669-76. PubMed ID: 19578008
[TBL] [Abstract][Full Text] [Related]
34. Secretagogin expression in tumours of the human brain and its coverings.
Pipp I; Wagner L; Rössler K; Budka H; Preusser M
APMIS; 2007 Apr; 115(4):319-26. PubMed ID: 17504298
[TBL] [Abstract][Full Text] [Related]
35. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD
J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895
[TBL] [Abstract][Full Text] [Related]
37. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
38. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
39. Histological and immunohistochemical studies on spontaneous rat astrocytomas and malignant reticulosis.
Nagatani M; Ando R; Yamakawa S; Saito T; Tamura K
Toxicol Pathol; 2009 Aug; 37(5):599-605. PubMed ID: 19487256
[TBL] [Abstract][Full Text] [Related]
40. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
